Bridgeway Capital Management’s Pacific Biosciences PACB Stock Holding History

Bridgeway Capital Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-275,200	Closed	-$1.42M	–	1340
2019 Q4	$1.42M	Sell	275,200 -30,000	-10%	-$152K	0.02%	651
2019 Q3	$1.57M	Hold	305,200	–	–	0.02%	600
2019 Q2	$1.85M	Hold	305,200	–	–	0.02%	557
2019 Q1	$2.21M	Hold	305,200	–	–	0.03%	491
2018 Q4	$2.26M	Sell	305,200 -65,000	-18%	-$412K	0.03%	454
2018 Q3	$2M	Hold	370,200	–	–	0.02%	636
2018 Q2	$1.31M	Buy	370,200 +195,200	+112%	+$542K	0.01%	770
2018 Q1	$359K	Buy	+175,000	New	+$454K	﹤0.01%	1166
2015 Q1	–	Sell	-249,100	Closed	-$1.95M	–	1514
2014 Q4	$1.95M	Hold	249,100	–	–	0.04%	524
2014 Q3	$1.22M	Hold	249,100	–	–	0.03%	678
2014 Q2	$1.54M	Sell	249,100 -1,050	-0.4%	-$5.25K	0.04%	601
2014 Q1	$1.34M	Buy	250,150 +1,050	+0.4%	+$6.64K	0.04%	645
2013 Q4	$1.3M	Sell	249,100 -28,400	-10%	-$130K	0.04%	646
2013 Q3	$1.53M	Sell	277,500 -280,000	-50%	-$972K	0.05%	530
2013 Q2	$1.41M	Buy	+557,500	New	+$1.39M	0.06%	487

Other funds holding PACB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

KLCMU

Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's PACB Position: Q1 2020 in Review

Bridgeway Capital Management sold out of Pacific Biosciences (PACB) in Q1 2020, closing a stake of 275,200 shares — an estimated $1.42M sold.

Bridgeway Capital Management first reported a position in PACB in Q2 2013 and held it in 15 quarters. The position peaked at $2.26M in Q4 2018. 132 funds tracked by Wall St. Rank hold PACB as of Q1 2020.

Bridgeway Capital Management reported no remaining Pacific Biosciences position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 275,200 Pacific Biosciences shares in Q1 2020, an estimated $1.42M.
Bridgeway Capital Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 15 quarters.
Bridgeway Capital Management's Pacific Biosciences position peaked at $2.26M in Q4 2018.
132 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.